Resumen

BARROS, Carolina et al. Diabetic Ketoacidosis Precipitated by COVID-19. Gaz Med [online]. 2021, vol.8, n.4, pp.290-293.  Epub 01-Feb-2022. ISSN 2183-8135.  https://doi.org/10.29315/gm.v1i1.505.

COVID-19 has a broad spectrum of presentation, ranging from asymptomatic to severe disease. Patients with comorbidities, such as cardiovascular and metabolic, have a higher risk of developing severe disease or even complications. COVID-19 may precipitate the onset of metabolic complications such as diabetic ketoacidosis. There have been reported cases of mild or even asymptomatic disease associated with states of ketoacidosis, and the virus may act as a precipitating factor for metabolic deterioration even in the absence of symptoms. Therefore, further clinical studies are imperative to understand the correlation between COVID-19 and diabetic ketoacidosis.

Palabras clave : COVID-19; Diabetic Ketoacidosis; SARS-CoV-2.

        · resumen en Portugués     · texto en Portugués     · Portugués ( pdf )